Enlivex Therapeutics Ltd. Made Big Gain

Enlivex Therapeutics Ltd. (ENLV:NASDAQ) jumped higher at $13.87, representing a gain of 22.7%. The stock got featured on our News Catalysts scanner on Tue 13 Oct 20 at 10:11 AM in the 'BIOTECH' category. From Mon 28 Sep 20, the stock recorded 60.00% Up Days and 63.64% Green Days

The stock spiked on Mon 05 Oct 20 at $15 with a volume of 7M+.

About Enlivex Therapeutics Ltd. (ENLV:NASDAQ)

Bioblast Pharma Ltd is an Israel-based development-stage biopharmaceutical company. The firm is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations.